Anavex Life Sciences Corp. (0HFR.L) LSE

4.78

-0.0814(-1.67%)

Updated at January 15 04:53PM

Currency In USD

Valuation

Market Cap759.08M
Enterprise Value656.5M
P/E Ratio-8.54
PEG Ratio2.35
Price/Sales Ratio0
Price/Book Ratio4.52
Enterprise/Revenue0
Enterprise/EBITDA-5.71

Fiscal Year

Fiscal YearSeptember 30, 2025
Most Recent QuarterJune 30, 2025

Profitability

Profit Margin0
Operating Margin0

Management Effectiveness

Return On Assets-0.47
Return On Equity-0.46

Income Statement

Revenue0
Revenue/Share0
Gross Profit0
EBITDA0
Net Income0
Diluted EPS-0.54

Balance Sheet

Total Cash101.16M
Total Cash/Share1.18
Total Debt0
Total Debt/Equity0
Current Ratio8.82
Book Value Per Share1.07

Price History

52-Week Change-58.9
52-Week High10.45
52-Week Low4.69
Moving Average 50 Days5.79
Moving Average 200 Days7.24

Statistics

Average Volume7,784
Shares Outstanding89.35M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A